Mangoceuticals, Inc.
MGRX
$0.34
$0.000.89%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -137.11% | -112.55% | -55.63% | -23.94% | 5.49% |
| Total Depreciation and Amortization | 135.69% | 12,386.25% | 3,689.47% | 4,461.20% | 2,837.75% |
| Total Amortization of Deferred Charges | -- | -200.00% | -200.00% | -- | -- |
| Total Other Non-Cash Items | 393.70% | 356.71% | 172.27% | 110.65% | 11.20% |
| Change in Net Operating Assets | 46.96% | -122.85% | -41.57% | -110.33% | 5,028.36% |
| Cash from Operations | -20.28% | -8.66% | 2.51% | 0.53% | 30.49% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -100.00% | -100.00% | -- | 1,957.14% |
| Total Debt Issued | 350.00% | 200.00% | 200.00% | -28.57% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 404.58% | 196.75% | 105.04% | -5.04% | -81.61% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -56.60% | -31.11% | 53.33% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 76.12% | 50.03% | 57.37% | 164.39% | -41.50% |
| Foreign Exchange rate Adjustments | 171.72% | 76.47% | 25.00% | -2,100.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 309.83% | 135.03% | 84.16% | 101.58% | -1,308.53% |